ARCHIVES

Olaparib, A PARP Inhibitor, Can Reduce Tumor Size In Advanced Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 33 No. 8 | August 27, 2010

Download PDF Visit The Full Archive

Related Articles

“Great Charlie Moertel Shootout: In Tucson Draws Laughs, Criticism

April 17, 1981

Modeling: Like The Sims But No Graphics

November 26, 2010

Guest Editorial: As ACS Turns 100, Society President Calls For Tools To Finish the Fight Against Cancer

May 17, 2013

Study Finds 4-20% Of Those With HTLV-3 Develop AIDs Within 32 Months Or Less

August 2, 1985

ASCO Recommends Aromatase Inhibitors As Adjuvant For Some Breast Cancer

July 30, 2010

Conversation with TCL:Demetri: Morcellation Worsens Outcomes In Patients with Undiagnosed Cancers

November 21, 2014